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Introduction
Glutamine synthetase (GS; EC 6.3.1.2, also known as -glutamyl:ammonia ligase) plays an essential role in nitrogen metabolism by catalyzing the ATPdependent condensation of glutamate and ammonia to form glutamine. The role of GS in humans depends on the tissue localization; in the brain it regulates the levels of toxic ammonia and converts neurotoxic glutamate to harmless glutamine, while in the liver, GS is one of the enzymes responsible for the removal of ammonia. Links with Alzheimer's plaque formation are well documented; levels of human GS (HsGS, also referred to as GLUL) are, for instance, higher in the cerebral spinal fluid of Alzheimer's patients. 1 GS is also one of the major oxidatively modified proteins in the hippocampus of patients with mild cognitive impairment. 2 The modification lowers the activity of the enzyme and contributes to glutamate dysregulation and impairment of neuroplasticity during the development of Alzheimer's. Recent studies indicate that GS is essential in early mouse development. 3 In bacteria and plants, the enzyme is responsible for fixation and re-assimilation of ammonia, allowing glutamine to be used as a nitrogen source for metabolism. Because of its importance, the enzyme has been used as a target for herbicides 4 and considered as a possible target for antimicrobial drugs, as summarized elsewhere. 5 The ground-breaking work of Eisenberg and coworkers 6, 7, 8, 9 resulted in a number of structures of Salmonella typhimurium GS (StGS) in complex with amino acids (substrates or inhibitors), metals (Mn 2+ , and thallium ions mimicking the ammonium substrate), and nucleotides (AMP or ADP), as well as a structure with the inhibitor phosphinothricin (PPT) bound together with Mn 2+ and ADP. These structures correspond to the ''taut'' (active) state that exists when multiple metal ions are bound. An additional structure represents the GS of Mycobacterium tuberculosis (MtGS) with bound AMP, 10 in a ''relaxed'' (inactive) form that is observed at lower concentrations of metal ions. A more recent report described MtGS in complex with a phosphorylated form of the inhibitor L-methionine-S-sulfoximine (i.e. MSO-P), Mg 2+ and ATP; this is also a "taut" form of GS. 11 The bacterial structures are all 5 dodecameric, with two hexameric rings of GS subunits stacked onto each other. The first eukaryotic GS structures represented the maize (Zea mays) protein (ZmGS) in complexes with: a) MSO-P, Mn 2+ and ADP, b) MSO, Mn 2+ and the ATP analogue AMP-PNP, and c) PPT-P, Mn 2+ and ADP. 12 Interestingly, although the fold of the subunit was similar, the arrangement was in this case that of a decamer, with two pentameric rings stacking. However, structural information concerning the mammalian enzymes has been lacking, limiting our understanding of how they differ from GSs of plants and bacteria.
In the present paper, we report the first structures of mammalian GSs, those from dog (Canis familiaris, CfGS) and human (HsGS), alone and in complex with metals, nucleotide and inhibitor. The results provide many new insights that will be useful in the design of novel antibacterial agents and herbicides.
Results

Biochemical characterization
The mammalian GSs appear to be less robust than the bacterial enzymes studied . CfGS and HsGS were extensively characterized in earlier 6 work, and shown to have similar catalytic properties. 13, 14 In preliminary kinetic experiments, we found that the same applied to the two proteins studied here.
Overall structures
The structure of the apo form of CfGS was solved by molecular replacement, using a pentamer of ZmGS/MnADP/MSO-P (PDB entry code 2D3A) 12 as search model, and refined to a resolution of 3 Å. Statistics for data collection and refinement are summarized in Table 1 . The final model consists of three pentamers (Figure 1(a) ), two of which are related by a 2-fold non-crystallographic operator, and constitute the biologically relevant decamer (Figure 1(b) ). The third pentamer in the asymmetric unit is also part of a decamer, by virtue of a 2-fold crystallographic axis. The decameric assembly is ~90 Å in size measured along the 5-fold axis, and 110 Å along the 2-fold axis. Well-defined electron density is observed for each subunit from Thr3 The HsGS/MnADP/P i structure was solved by molecular replacement, using a subunit of the ZmGS/MnADP/MSO-P (PDB entry code 2D3A) 12 
Active site
A GS decamer has 10 active sites, each located at the interface of two adjacent subunits in the pentameric ring. The N-terminal -grasp domain of one subunit interacts with the highly curved -sheet of the C-terminal catalytic domain in the next subunit, so forming a funnel-shaped pocket. The "funnels" face outwards in the pentamer shown in Figure 1 (a). Because the two pentamers stack back-to-back ( Figure 1(b) ), the active sites in the second pentamer are oriented in the opposite direction. They are shifted relative to those of the first by ~35°, i.e. 1/2 of the fivefold rotation component, to give a staggered arrangement.
The most complete picture of interactions within the mammalian GS active site is provided by the HsGS/MnADP/MSO-P structure ( Figure 3 ). The adenine ring of ADP lies in a primarily hydrophobic pocket bounded by Trp130, Arg262, Tyr336 and Pro208 ( Figure 3(a) ). The side chains of Trp130 and Arg262 participate in an aromatic-arginine planar stacking interaction, while Pro208 adopts a cis conformation. All of these residues are highly conserved in eukaryotic GS sequences.
The only hydrogen bonds are provided by the interactions of Ser257 with both N1 and N6 of the adenine moiety ( Figure 3(b) ). The ribosyl group of ADP, which adopts a C2'-endo conformation, does not make hydrogen bonds with protein ligands. The -and -phosphate groups, however, make a large number of interactions with protein side chains as well as two of the three Mn 2+ ions in the active site (those designated as n2 and n3, in accordance with earlier conventions). 6, 11 Every polar atom of MSO-P (which is expected to bind at the position of the glutamate substrate) makes one or more interactions with the protein, either directly, or via metal-mediated contacts involving all three Mn 2+ ions (Figure 3 (b)). Consistent with previous studies, the phosphate group is attached to the sulfoximido nitrogen of the preferred S enantiomer.
11,15
The binding of ADP in the HsGS/MnADP/P i structure is identical to that found in HsGS/MnADP/MSO-P. Three Mn 2+ ions are observed in the same positions, and the free phosphate occupies the site of the phosphate in MSO-P. An additional Mn
2+
ion makes contacts with Glu196 as well as the inorganic phosphate.
The active site of the CfGS apo structure contains only a single Mg 2+ (rather than Mn 2+ ) ion, bound at the n1 position.
Conformational changes on ligand binding
Comparison (Table 2 ). Using the yardstick introduced above, the distance between 75 and 317 is 5.8 Å in HsGS/MnADP/P i , as observed for HsGS/MnADP/MSO-P. We conclude that the active site closes when the nucleotide is bound, and that few additional changes occur on binding of the amino acid substrate (as modeled from the MSO moiety). There are no major allosteric changes within or between the pentamers.
Comparison of mammalian GSs and ZmGS
CfGS and HsGS share ~50% amino acid sequence identity with the maize enzyme, ZmGS, as illustrated in the structure-based sequence alignment presented in Residues lining the active sites are also highly conserved. The only notable difference is that Ser187 of the maize enzyme replaces Ala191 in human and dog GS. The serine residue provides a single hydrogen bond to the ribosyl moiety of the nucleotide that is not found in mammalian GSs. We predict that there should be a cis proline at Pro204 in ZmGS, as seen for the mammalian proteins; such a feature might easily have been 11 missed at the lower resolution available for the maize structures (2.63 Å, at best). In Figure 4 (b), we compare the conformation of the HsGS/MnADP/MSO-P complex to that of ZmGS/MnADP/MSO-P. The conformations observed in the ZmGS structures are in fact all very similar to both HsGS/MnADP/P i and HsGS/MnADP/MSO-P, and distinct from that observed for apo CfGS (Table 2) .
Comparisons with bacterial GSs
Structure-based sequence alignments comparing the eukaryotic GSs with the 
Discussion
GS has been proposed to use a two-step reaction mechanism. 16 The one from the -grasp domain, and two from the catalytic domain; one of the latter includes three residues (Arg319, Glu338 and Arg340) that make direct contact with glutamate or metal. Binding of the ATP causes changes in GS that prepare it for binding to glutamate.
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The movements in the -grasp domain involve Asp76, which interacts with Arg319 (e.g. from chains E and A, respectively). The arginine in turn binds to the inorganic phosphate in the HsGS/MnADP/P i structure, and the phosphate group of MSO-P in the HsGS/MnADP/MSO-P structure. Arg319 is disordered in the CfGS apo structure. Asp76 also interacts with Arg324, which moves closer in the complexed structures, allowing it to bind the -phosphate of the nucleotide. Proper positioning of Asp76 is thus crucial for nucleotide binding. When the A molecules are superimposed, it is seen that the same role is fulfilled by Glu69 in chain E of the maize enzyme, and by Asp68 of chain F in the hexamer of MtGS.
The single magnesium ion seen in the apo CfGS structure (n1) is that most dependent on protein contacts; these will favor its binding even in the absence of substrates. The divalent cation will also serve to compensate for the charges on the three acidic residues involved (glutamates 136, 196 and 203). The other two cations are apparently bound only as glutamate and ATP enter the site. A single chloride is bound at a subunit-subunit boundary in both apo and complexed structures, and may stabilize the pentamer in the biological setting. Physiologically-relevant levels of chloride have been reported to stabilize the CfGS 13 and HsGS, 14 and increase the affinity of bovine GS for magnesium or manganese 2-4 fold. 18 In some subunits of the CfGS structure, electron density is observed for the C- vital that normal functions of mammalian GS are not interfered with, comparisons of mammalian and plant GS structures will be important in future herbicide design.
Mammalian GSs have a longer N-terminus than ZmGS (Figures 2 and 4) , which may add to the stability of the pentamer through slightly larger contact surfaces in the middle of the doughnut-shaped pentameric ring (Figure 1(a) ). However, most other 15 structural features are similar, or not expected to result in functional differences. In particular, comparisons of the active sites of plant GSs with those of mammalian GSs indicate that they are highly similar. In addition to the almost complete conservation of the residues that interact with glutamate, magnesium ions and ATP, residues of the ammonia-binding site are highly conserved. For instance, the equivalent of Val197 is completely conserved in all species, prokaryotic and eukaryotic. This residue makes van der Waals contact with the methyl group of MSO-P in the structure reported here.
Therefore, compounds that target the plant GS active site would be expected to inhibit the mammalian enzymes, as well. Humans have some protection from the negative effects of ammonia accumulation, as alternate routes for its removal exist. However, like MSO, the herbicide is neurotoxic, provided that enough crosses the blood-brain barrier. 21, 22 Furthermore, glufosinate is toxic to bacteria, including essential symbionts. Our structures suggest that a safer approach would make use of noncompetitive inhibitors that target portions of the enzyme affected by the conformational changes. In general, residues in these regions are much less conserved than those in the active site.
Comparisons with the more distantly related bacterial GSs show that, given the very low sequence identity, the structural conservation in the active site is remarkable ( Figure 5 ). Therefore, the enzymes are expected to have the same reaction mechanism, consistent with our observation that they have comparable levels of activity. Bacterial hexamer-hexamer contacts are much larger than eukaryotic pentamer-pentamer contacts, in line with the observed relative stability of the proteins. Bacterial GS is highly stable, while the mammalian enzymes have a tendency to be unstable or insoluble in vitro, as evident here. There is a long Cterminal extension in the bacterial enzymes that includes a tyrosine that can be adenylylated, resulting in lower activity. This segment is missing in the mammalian GSs, and so regulation of this kind is not possible.
The structure-based sequence alignment further illustrates the fact that the bacterial enzymes can exist in two different conformations, which are distinguished by a three-residue register shift of the -strand starting at Glu214 (MtGS numbering). 11 The residues involved make interactions with glutamate and ATP, and so the relaxed version (boxed in the 1HTO sequence in Figure 2 ) is by definition inactive. In the three structures reported here, there is a metal ion present at the n1 site and therefore they are in the taut (active) conformation. In principle, low metal concentration could also cause a strand shift in the eukaryotic enzymes. Since there is a deletion in this region (after Pro199 in mammalian GS), a two-residue register shift would be expected instead of the three-residue one observed in prokaryotic GSs.
However, we have no evidence at present that such a strand shift does in fact occur in the mammalian GSs.
Several features are particularly relevant for the design of drugs directed specifically against the bacterial GSs. We emphasize the fact that the relative placement and orientation of glutamate, metals, ATP and ammonia are all extremely similar in the mammalian and bacterial enzymes ( Figure 5 ). The residues defining the glutamate site are identical, and those binding to metal are almost completely conserved. However, the nature of the nucleotide site is entirely different. Therefore, we suggest that the design of specific inhibitors should focus on the nucleotidebinding site. Although extension of compounds into the metal and/or amino acid binding sites could be useful for reasons of solubility or uptake, these sites do not offer any opportunities for achieving selectivity. Combined with the facts that MtGS is essential, 23, 24, 25 and that its extracellular activity is important to the pathogen 26 (i.e.
drugs need not penetrate the formidable mycobacterial cell wall), prospects for the design of effective anti-tubercular drugs directed at glutamine synthetase seem good.
Experimental procedures Cloning, protein expression and purification
Plasmid (pET-SGS) 13 encoding C-terminal His-tagged CfGS was kindly mM Na-phosphate, 10%(v/v) glycerol, 0.5 mM TCEP, 500 mM NaCl, and 10 mM imidazole (pH 7.5). IMAC-wash and elution buffers were the same except that the imidazole concentration was raised to 25 and 500 mM, respectively. Gel filtration buffer contained 20 mM HEPES, 300 mM NaCl, 10%(v/v) glycerol, 0.5 mM TCEP (pH 7.5). Fractions containing HsGS were pooled and the TCEP concentration adjusted to 2 mM. ATP and MnCl 2 were added to concentrations of 10 mM each, after which purified HsGS was concentrated using an Amicon Ultra MWCO 10000 concentrator to 40 mg/mL, as measured by BioRad Bradford assay; purified protein was stored at -80 C. Grenoble, France. The data were integrated and scaled using XDS/XSCALE. 33 The crystals belonged to space group C2, and the Matthews coefficient suggested the presence of two pentamers in the asymmetric unit.
Crystallographic statistics for the three data sets are summarized in Table 1 .
Structure determination and refinement
The structure of CfGS was solved by molecular replacement using AMoRe 34 as implemented in the CCP4 interface, 35 using a pentamer of ZmGS (PDB entry NCS operators relating all the subunits to one monomer of ZmGS structure were obtained using the lsq options in O. Initial crystallographic refinement was performed using the CNS package, 37 and strict NCS constraints were maintained within and between the pentamers. The model was first subjected to a simulated-annealing Table 1 .
The structure of HsGS/MnADP/P i was solved by molecular replacement using Table 1 .
HsGS/MnADP/P i was used as an initial model for the MSO-P complex structure; the two pentamers of the decamer were placed by molecular replacement using MolRep. Refinement was conducted using REFMAC5 including NCS restraints and individual B-factor refinement. Coot was used for model building. In the later stages of refinement, TLS parameters were included and refined. Statistics for the final refined model are given in Table 1 .
Structural comparisons and structure analysis
Structures were compared using the programs O and LSQMAN. 45 Figures were prepared with Pymol 46 and ChemDraw (CambridgeSoft Corp).
Protein Data Bank accession codes
Coordinates and structure factor data were deposited in the Protein Data Bank, with accession codes 2UU7, 2OJW, and 2QC8 for the apo CfGS and HsGS/MnADP/P i and HsGS/MnADP/MSO-P structures, respectively. Structures were compared using molecule A with a cutoff of 0.7 Å in the program LSQMAN. At top/right is the r.m.s. distance in Å. At bottom/left, the number of residues matched is reported; the sequence identity within that region is given in parentheses.
Number of residues in the sequence is shown in bold on the diagonal.
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